Prediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade

Core Insights - Companies prioritizing dividends may have less capital for reinvestment, potentially leading to lower returns, although some dividend stocks can outperform growth stocks [1] Group 1: Dividend Payers - AbbVie is a notable dividend payer, having raised its dividends for 53 consecutive years, and is part of the Dividend Kings group [4] - AbbVie offers a forward yield of 2.8%, significantly higher than the S&P 500's average of 1.2%, with a cash payout ratio of 61.8% [5] - The company has a diversified revenue stream from various therapeutic areas, which helps maintain demand for its products regardless of economic conditions [6] Group 2: Growth Prospects - AbbVie is expected to see revenue and earnings growth driven by its immunology drugs, Skyrizi and Rinvoq, which are expected to continue strong sales growth into the next decade [7] - The company has successfully navigated a major patent cliff and secured Rinvoq's patent exclusivity until 2037 in the U.S. [7][9] - AbbVie is anticipated to launch new medicines, further enhancing its top-line growth without facing significant patent losses through the end of the decade [9]